logo
The hidden physical powers that help women outlive men

The hidden physical powers that help women outlive men

CNN07-07-2025
EDITOR'S NOTE: Starre Vartan is the author of 'The Stronger Sex: What Science Tells Us About the Power of the Female Body,' which will be published on July 15.
People who lived through the Irish Potato Famine, enslavement in Trinidad and Icelandic measles epidemics all have something in common: Women outlive men in dire circumstances.
That's because the female body is built for resilience and longevity, as I found while researching for my new book, 'The Stronger Sex.'
Despite having more complex reproductive organs and the burdensome, sometimes fatal, functions that come with them — menstruation, pregnancy, childbirth and breastfeeding — female bodies tend to outlast male bodies. And that's the case even though girls in many parts of the world have access to fewer resources, such as food and medical care, than boys do.
That female toughness holds true in extreme circumstances, as Virginia Zarulli, now an associate professor of demography at Italy's University of Padua, found when she analyzed survival data across seven historical populations experiencing famines, epidemics and enslavement.
Under these brutal conditions, women outlived men across almost all ages and locations, including among the 'high-mortality' populations who confronted famine in Ukraine, Ireland and Sweden; enslavement in Trinidad; and measles epidemics in Iceland, according to her 2018 study, published in the journal PNAS. Even newborn girls in these environments had a higher survival rate than newborn boys — a hint that the female survival advantage is rooted in biology.
Essential female strength also shows up today in places where women experience fewer extreme physical stresses overall: 'When we analyze the empirical data, for modern people it shows that death rates for men are higher than for women, pretty much at every age,' Zarulli said.
Recognizing and building on these sex-based differences can help transform how we approach health care, including treatments for cancer and vaccine protocols — making medicine more precise, personalized and effective, especially for women.
People assigned female at birth have two X chromosomes, a fundamental advantage over XY, the chromosomes males have at birth. That's because the X chromosome is much larger, containing roughly 10 times more genes. Female bodies therefore have access to a wider range of immune genes, making their defense system remarkably strong and diverse. As neurogeneticist and evolutionary biologist Dr. Sharon Moalem wrote in 'The Better Half: On the Genetic Superiority of Women,' his book about the XX chromosome advantage, 'Women have immunologically evolved to out-mutate men.' Since viruses and bacteria are always mutating, an immune system that can quickly adapt is more resilient.
Estrogen, generally higher in female bodies, also confers a variety of immune advantages.
As a result, female mammals — including humans — have better-equipped immune systems, in both their innate, generalized responses and their adaptive, specialized responses. Female bodies also have higher counts of active neutrophils, the most common type of white blood cell that fights infections.
Scientists have also found that female bodies have more robust B cell activity — the action of white blood cells that adapt to fight off viruses or bacteria. This advantage may also be due in part to estrogen, and researchers are trying to tease apart what is mediated by hormones, what is affected by genes and what might be attributable to other causes.
Women produce more targeted antibodies to fight infections and also retain immunological memory longer, making their bodies more adept at responding to future infections, according to researchers. This all leads to 'the very well-known phenomenon that males tend to be more susceptible to a lot of diseases than females — though not in every disease or every individual, of course,' said Marlene Zuk, a Regents Professor and evolutionary biologist at the University of Minnesota in St. Paul.
Since female bodies mount stronger immune defenses, they generally have a stronger vaccine and virus response, a greater ability to fight off sepsis and a decreased risk of some cancers. The downside of this powerful system, however, is that women get more autoimmune diseases than men do. Women are also more likely to live with chronic illness after surviving diseases that would have killed male bodies.
Testosterone also seems to be an immune disadvantage, and males have more of that hormone than females do. Zuk said that in early experiments scientists found they could 'neuter male animals and their immunity would get better or inject female animals with testosterone and their immunity would get worse.'
Why? It may be that the testosterone enables male animals toward greater reproductive success by 'living hard and dying young,' Zuk said. Some of the female immune advantage may be male immune disadvantage, and while it's accepted that hormones affect immunity, determining to what degree is an ongoing research question.
Some scientists argue that lifestyle and culture lead to a significant part of the male longevity disadvantage. As a population, men tend to smoke more, drink more alcohol and engage in riskier activities than women, and men tend to exclude most women from more physically dangerous jobs.
Studies focused on what happens when women adopt some of the unhealthy habits traditionally more likely among male populations, such as smoking, still show that women live longer than men, Zarulli said. 'In populations where men and women had the same lifestyle, there was still a difference in mortality — women had a higher life expectancy than men.'
The female advantage is likely due to more than genetic and hormonal factors, according to new research: It's also found in the very structure of women's bodies.
At North Carolina State University, a team led by microbial ecologist Erin McKenney and forensic anthropologist Amanda Hale conducted a landmark study measuring the lengths of the small intestines in cadavers for the first time since 1885.
The team discovered that women's small intestines were significantly longer than men's — an advantage that allows women to extract more nutrition from the same quantity of food.
This finding, published in the journal PeerJ in a 2023 paper, might be explained by the extra demands on female bodies throughout human history: 'The vast majority of the nutrients you need to replenish your system — especially during reproduction and nursing, like protein and fat — that's what's being absorbed by your small intestine,' Hale said.
This could be a key piece of the 'Female Buffering Hypothesis' — the idea that female biology evolved to withstand environmental and physiological stress better — according to Hale.
Traditional medical research has long ignored the complexities of the female body. As these genomic and physiological functions are better studied and understood, the drivers behind the strength and resilience of the female body will come into focus. This knowledge will inform more targeted treatments for infection and immunity—for all bodies.
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

iCRYO's CEO and CAO to Join Vitality Business Summit 2025 as Featured Speakers
iCRYO's CEO and CAO to Join Vitality Business Summit 2025 as Featured Speakers

Yahoo

time5 hours ago

  • Yahoo

iCRYO's CEO and CAO to Join Vitality Business Summit 2025 as Featured Speakers

DALLAS, Aug. 6, 2025 /PRNewswire/ -- iCRYO, a leading health, wellness, and longevity franchise, is excited to announce that its CEO and Co-Founder, Kyle Jones, and Chief Administrative Officer (CAO), Scott Briner, will be featured speakers at the Vitality Business Summit 2025. The summit, scheduled for October 3-5, 2025, at the Hilton DFW Lakes Executive Conference Center in Dallas, Texas, is organized and hosted by brothers Chris and Brad Himel of Himel Health, longtime consultants for health and wellness clinics. Leveraging their network, they are bringing together brand entrepreneurs, clinic owners, and other health enthusiasts to shape the future of health and wellness. Emphasizing practical solutions over passing trends, The Vitality Business Summit promises to equip attendees with the tools to build scalable, purpose-driven businesses. Kyle W. Jones, as a pioneer in cryotherapy and holistic wellness going back to 2015, will join a host of other accomplished leaders in the industry, including acclaimed speaker and author Tim Storey, motivational speaker Jenn Drummond, BrainTap founder Dr. Patrick Porter, business coach Raquel Diehm, and OxyHealth CEO Dr. Mayur Patel, to name a few. "I'm thrilled to speak at the Vitality Business Summit and share the strategies that have fueled iCRYO's growth while keeping wellness accessible," said Jones. "At the same time, this event is a catalyst for change, with innovation and adoption moving ever faster in this space. This summit offers us a chance to keep our finger on the pulse and connect with other professionals building businesses that will make a lasting impact." iCRYO's CAO and former hospital CEO Scott Briner echoed Jones' thoughts, adding, "I'm honored to join Kyle as a speaker and represent iCRYO at the Vitality Business Summit this fall. We've developed what we believe is the new industry-standard for medical care in a retail environment, and we're proud to share it with the world any chance we get. However, we're always looking to learn, grow, and improve iCRYO's service and offerings, and this event gives us that chance." The summit caters to a diverse audience, from solo practitioners to multi-unit clinic owners, offering unparalleled opportunities to learn sales and marketing frameworks used by successful clinics, network with world-class experts, explore dozens of vendors showcasing the latest in wellness modalities and therapies, develop a tailored growth plan, and create lasting partnerships. Early Bird pricing offers up to 50% off General Admission and 33% off VIP tickets, which include a VIP Lunch with speakers on Sunday. Attendees are encouraged to secure their spots now as both General Admission and VIP tickets are going fast with these early bird offers. Event Details: Date: October 3-5, 2025 Location: Hilton DFW Lakes Executive Conference Center, Dallas, Texas Tickets: Available at About iCRYO Founded in 2015, iCRYO's mission is to elevate the quality of life of its team members, guests, and franchisees by providing affordable, professional, and convenient personal health services while raising the standard as a global wellness brand. To learn more about its services, locations, and franchise opportunities, visit iCRYO Media Contact Robbie JenkinsDirector of View original content to download multimedia: SOURCE iCRYO Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Cell Line Development Market Outlook Report 2025-2034: PromoCell, Novartis, Genscript Biotech, Sartorius, and Thermo Fisher Scientific Dominate the Industry
Cell Line Development Market Outlook Report 2025-2034: PromoCell, Novartis, Genscript Biotech, Sartorius, and Thermo Fisher Scientific Dominate the Industry

Yahoo

time8 hours ago

  • Yahoo

Cell Line Development Market Outlook Report 2025-2034: PromoCell, Novartis, Genscript Biotech, Sartorius, and Thermo Fisher Scientific Dominate the Industry

Booming Biologics and Biosimilars Market Drives Global Cell Line Development Surge; CDMOs and Technological Advancements Key to Growth Cell Line Development Market Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "Cell Line Development Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" has been added to offering. The Global Cell Line Development Market was valued at USD 7.5 billion in 2024 and is estimated to grow at a CAGR of 10.2% to reach USD 19.7 billion by 2034. Market expansion is being fueled by a growing focus on biologics and biosimilars, particularly as the pharmaceutical industry shifts toward personalized therapies and precision medicine. The surge in demand for monoclonal antibodies, vaccines, and recombinant proteins has placed strong emphasis on the development of highly stable and productive cell lines. The increase in chronic illnesses-such as autoimmune diseases, cancer, and infectious disorders-has led to the rising adoption of biologics, which depend heavily on well-characterized cell lines. This has also elevated the need for quality-controlled production systems. Contract development and manufacturing organizations (CDMOs) have contributed significantly to market momentum. Small and mid-sized biotech firms are increasingly outsourcing their cell line development to CDMOs to reduce overhead costs and accelerate timelines, benefiting from their technical expertise, scalable platforms, and regulatory compliance with agencies like the FDA. This trend allows companies to focus on core competencies such as research and innovation while leveraging CDMOs for end-to-end services including cell line screening, clone selection, process optimization, and GMP manufacturing. These partnerships also offer access to advanced technologies, streamlined workflows, and proven quality assurance frameworks, enabling faster entry into clinical trials and reducing risks associated with internal capacity limitations. The reagents and media segment generated USD 3.4 billion in 2024. This segment continues to dominate due to its central role in cell growth and maintenance across both R&D and production stages. With a notable increase in the use of mammalian cells for biologics manufacturing, the demand for high-efficiency reagents and cell culture media has surged. A growing preference for protein-free and serum-free media is helping the segment gain traction, offering improved scalability, reduced risk of contamination, and consistency in large-scale production environments. Such media types are essential for regulatory approval and efficiency in biologics manufacturing, which demands stringent process control. In terms of cell type, the mammalian cells segment generated the highest revenue in 2024, accounting for 71.4%. Their dominance is linked to their superior ability to express human-compatible therapeutic proteins with accurate post-translational modifications. Widely used cell lines such as CHO and HEK-293 are favored in biologics production due to their robust protein folding, glycosylation, and scalability. Technological progress in gene editing tools, such as CRISPR-Cas9, combined with automation and high-throughput systems, continues to enhance the speed and stability of mammalian cell line development, further reinforcing their leadership in the market. The United States Cell Line Development Market was valued at USD 2.6 billion in 2024, driven by a combination of advanced biopharma infrastructure, high rates of chronic disease, and strong adoption of cutting-edge biologic therapies. The country's well-established pharmaceutical ecosystem, which includes top-tier biotech firms and extensive R&D investment, plays a pivotal role in expanding the market. Research institutions and innovation hubs across the US are also accelerating technological advancements in gene editing and automated platforms, leading to faster and more efficient development cycles. Government and private sector funding are also propelling innovation, further supporting the country's leadership in the field. Key companies operating in the Global Cell Line Development Market include PromoCell, Novartis, Genscript Biotech, Sartorius, Thermo Fisher Scientific, ProBioGen, Cytiva (Danaher Corporation), ASIMOV, Advanced Instruments, Sigma Aldrich (Merck KGaA), Eurofins Scientific, WuXi AppTec, Aragen Life Sciences, Fyonibio, and Lonza Group. Top-tier players in the cell line development space are heavily investing in technological innovations like automated cell screening platforms, single-use bioreactors, and CRISPR-based genome editing. Many companies are forming strategic alliances with biotech firms and CDMOs to enhance service offerings and expand production capabilities. Acquisitions are also a popular move to integrate novel technologies or gain regional access. Firms are focusing on R&D to develop serum-free and chemically defined media, helping improve regulatory compliance and scalability. Comprehensive Market Analysis and Forecast Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape Competitive landscape with Porter's Five Forces and PESTEL analysis Market size, segmentation, and regional forecasts In-depth company profiles, business strategies, financial insights, and SWOT analysis Key Attributes Report Attribute Details No. of Pages 145 Forecast Period 2024-2034 Estimated Market Value (USD) in 2024 $7.5 Billion Forecasted Market Value (USD) by 2034 $19.7 Billion Compound Annual Growth Rate 10.2% Regions Covered Global Key Topics CoveredChapter 1 Methodology and ScopeChapter 2 Executive Summary2.1 Industry 360 synopsis2.2 Key market trends2.2.1 Regional2.2.2 Products & services2.2.3 Source2.2.4 Cell line2.2.5 Application2.2.6 End use2.3 CXO perspectives: Strategic imperatives2.3.1 Key decision points for industry executives2.3.2 Critical success factors for market players2.4 Future outlook and strategic recommendationsChapter 3 Industry Insights3.1 Industry ecosystem analysis3.1.1 Supplier landscape3.1.2 Value addition at each stage3.1.3 Factors affecting the value chain3.2 Industry impact forces3.2.1 Growth drivers3.2.1.1 Growing vaccine production worldwide3.2.1.2 Increasing prevalence of cancer across the globe3.2.1.3 Technological innovations in cell line development3.2.1.4 Growing biotechnology industry3.2.2 Industry pitfalls and challenges3.2.2.1 Complex regulatory landscape3.2.2.2 Challenges related to stem cell research3.2.3 Market opportunities3.2.3.1 Emerging applications in personalized medicine and regenerative therapies3.2.3.2 Adoption of artificial intelligence in cell line optimization3.3 Growth potential analysis3.4 Regulatory landscape3.4.1 North America3.4.2 Europe3.4.3 Asia Pacific3.4.4 Latin America3.4.5 Middle East and Africa3.5 Future market trends3.6 Emerging therapeutic applications of CHO cell lines3.7 Technology landscape3.7.1 Current technological trends3.7.2 Emerging technologies3.8 Porter's analysis3.9 PESTEL analysisChapter 4 Competitive Landscape, 20244.1 Introduction4.2 Company market share analysis4.3 Company matrix analysis4.4 Competitive analysis of major market players4.5 Competitive positioning matrix4.6 Key developments4.6.1 Merger and acquisition4.6.2 Partnership and collaboration4.6.3 New product launches4.6.4 Expansion plansChapter 5 Market Estimates and Forecast, By Products & Services, 2021 - 2034 ($ Mn)5.1 Key trends5.2 Reagents and media5.3 Equipment5.3.1 Incubator5.3.2 Centrifuges5.3.3 Bioreactors5.3.4 Storage equipment5.3.5 Microscopes5.3.6 Electroporators5.3.7 Fluorescence-activated cell sorting5.3.8 Other equipment5.4 Accessories and consumables5.5 ServicesChapter 6 Market Estimates and Forecast, By Source, 2021 - 2034 ($ Mn)6.1 Key trends6.2 Mammalian6.2.1 Chinese Hamster Ovary (CHO)6.2.2 Human Embryonic Kidney (HEK)6.2.3 Baby Hamster Kidney (BHK)6.2.4 Murine myeloma6.2.5 Other mammalian sources6.3 Non-mammalian6.3.1 Insects6.3.2 AmphibiansChapter 7 Market Estimates and Forecast, By Cell Line, 2021 - 2034 ($ Mn)7.1 Key trends7.2 Recombinant7.3 Hybridomas7.4 Continuous cell lines7.5 Primary cell linesChapter 8 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)8.1 Key trends8.2 Bioproduction8.3 Drug discovery8.4 Toxicity testing8.5 Tissue engineering8.6 ResearchChapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)9.1 Key trends9.2 Pharmaceutical and biotechnology companies9.3 Academic and research institutes9.4 Contract research organizations (CROs)Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)10.1 Key trends10.2 North America10.2.1 U.S.10.2.2 Canada10.3 Europe10.3.1 Germany10.3.2 UK10.3.3 France10.3.4 Italy10.3.5 Spain10.3.6 Netherlands10.4 Asia Pacific10.4.1 China10.4.2 Japan10.4.3 India10.4.4 Australia10.4.5 South Korea10.5 Latin America10.5.1 Brazil10.5.2 Mexico10.6 Middle East and Africa10.6.1 South Africa10.6.2 Saudi Arabia10.6.3 UAEChapter 11 Company Profiles11.1 Advanced Instruments11.2 Aragen Life Sciences11.3 ASIMOV11.4 Cytiva (Danaher Corporation)11.5 Eurofins Scientific11.6 Fyonibio11.7 Genscript Biotech11.8 Lonza Group11.9 Novartis11.10 ProBioGen11.11 PromoCell11.12 Sartorius11.13 Sigma Aldrich (Merck KGaA)11.14 Thermo Fisher Scientific11.15 WuXi AppTecFor more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Cell Line Development Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Breathwork, Biohacking, and Cryotherapy: New Buzzwords for Modern Business Travelers
Breathwork, Biohacking, and Cryotherapy: New Buzzwords for Modern Business Travelers

WIRED

time9 hours ago

  • WIRED

Breathwork, Biohacking, and Cryotherapy: New Buzzwords for Modern Business Travelers

Aug 6, 2025 11:02 AM A new wave of luxury wellness facilities are catering to travelers looking to maintaining their health goals alongside high-powered schedules. Peptide cocktails, plasma exchange therapy, infrared sauna sessions, and methylene blue drips. These are just a few of the biohacks that keep Peter Phillips feeling invincible. For the past three years, the 53-year-old tech executive has worked with doctors at Extension Health, a longevity clinic in New York City, to craft a blueprint to help him combat the declines that come with age. 'I'm on the cusp of immortality,' he says. Every six weeks, he pops into the clinic for a full body reboot that typically includes a nervous system reset and hyperbaric oxygen therapy. Even when on the road, Phillips fastidiously seeks out biohacking lounges and hotels that offer recovery modalities like IV drips and red-light therapy. Recovery and performance used to be reserved for retreats, but high-performing business executives can't always afford to catch up later. Today, it's not unusual for CEOs to fly from NYC to Dubai or Bangkok for 48 or even 24 hours. Looking for an extra edge, frequent business travelers are turning to therapies used by professional athletes to maintain peak mental and physical health while balancing demanding work schedules. This story is part of The New Era of Work Travel , a collaboration between the editors of Condé Nast Traveler and WIRED to help you navigate the perks and pitfalls of the modern business trip. When you're constantly on the go—changing time zones, eating inconsistently, navigating long workdays, and adapting to new environments—your body is in a near-constant state of stress, says Dr. Jonathan Leary, founder of Remedy Place, a social wellness club with locations in New York, Boston, and Hollywood. Today's executives aren't interested in traditional spa therapies. They gravitate toward evidence-based interventions, such as circadian rhythm realignment, heart rate variability-guided recovery protocols, and metabolic optimization programs that deliver measurable performance outcomes. These aren't just long-term investments in your health, they're powerful tools for restoring balance, reducing inflammation, supporting immunity, and improving sleep and recovery in real time, says Dr. Leary. A new wave of luxury wellness facilities and bleisure trips now cater to business travelers who are obsessed with maintaining their health goals alongside high-powered schedules that take them all over the globe. 'Business travel isn't just about surviving jet lag anymore,' says Dave Asprey, founder of Upgrade Labs, a chain of biohacking facilities in North America. 'It's not about bouncing back; it's about staying ahead. Recovery is no longer a luxury, it's a strategy.' Chip Conley, the 64-year-old founder of the Modern Elder Academy in New Mexico seeks out cryotherapy whenever he's on the road. As little as five minutes in these chambers with temperatures as low as -220 degrees Fahrenheit can provide an endorphin boost and help reduce inflammation, according to studies. 'It restores me to a place of revitalization in a matter of minutes,' he says. Rustan Panday, a 56-year-old chairman of a publishing company in Stockholm says he finds cryotherapy and infrared sauna sessions more restorative than a workout. He belongs to V Social Club, a members-only longevity center in Stockholm, and visits three times a week. Cellgym, a device that purportedly facilitates anti-aging by enhancing the function of mitochondria, the powerhouses of our cells, is his go-to therapy. 'I feel so happy and alive after a session,' he says. When he's on business in New York, he books ahead at Remedy Place so he can replicate his routine. Hotels are also attracting business executives with longevity-focused programs and amenities. 'More people are looking for places they can work, relax, and get a dose of wellness, whether that's a workout or a restorative spa treatment,' says Tammy Pahel, Vice President of Spa and Wellness Operations at Carillon Miami Wellness Resort. Busy professionals now expect to recharge between meetings at the resort's 70,000 square-foot-spa for a 30-minute quantum harmonic sound therapy session, which helps reduce stress and sharpens mental focus, and sleep through the night on. And the resort's AI-powered Bryte Smart beds, which have been shown to support sleep efficiency and combat jet lag. Equinox Hotel in New York is the epitome of bleisure. The flagship property from the uber exclusive fitness club seamlessly integrates health, sleep, work, indulgence, and relaxation into the guest experience. Around 35% percent of guests are business travelers, who book not just for the 60,000 square-foot gym, but also the proprietary in-room sleep systems that create the optimal environment for solid Zzzzs and biohacking spa therapies. The Estate, a new longevity-driven hospitality brand from hotelier Sam Nazarian and life coach Tony Robbins, takes things one-step further, providing access to extensive diagnostic testing, including full-body MRIs and telehealth consultations. The first outpost is slated to open in Los Angeles by the end of 2025. Kenneth Ryan, the Estate's chief longevity officer, anticipates more than 20% of guests and members will be high-frequency business travelers. 'We're reinventing the way they live on the road,' he says. 'Wellness isn't just an amenity; it's embedded in the infrastructure. You'll have direct access to physiotherapists, professional trainers, and lead massage therapists.' Six Senses Hotels Resorts Spas, a pioneer in the wellness space, is also evolving to accommodate the new bleisure traveler. In 2022, Six Senses opened an outpost of London-based longevity clinic RoseBar within its boho-chic Ibiza property. The partnership was such a success that the brand is expanding its regenerative wellness clinic partnerships across its portfolio, including its forthcoming properties in Tel Aviv and Dubai. 'Business travel has become a strategic component of executive wellness routines rather than a disruption to them,' says Anna Bjurstam, the brand's head of wellness. This demographic is pursuing '360- degree wellness escapes' that integrate performance optimization into their professional obligations, she says. The brand's most-requested services from business travelers now include comprehensive biometric tracking and optimization consultations, sleep enhancement programs, and stress-resilience training incorporating sound baths, breathwork, and mediation, says Bjurstam. Six Senses Place London embodies this evolution. When it opens later this year, it will house a medical longevity clinic and offer AI-driven health analytics, performance nutrition counseling, and every imaginable biohack. Experts are still undecided whether these cutting-edge therapies will actually extend lifespan. But for travelers like Conley, the point is more about feeling good when he's on the go. 'Travel wears you out,' he says. 'Now, there are so many options for replenishment no matter what city or timezone you're in.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store